National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

immunoadjuvant QS-DG
A synthetic saponin, chemically identical to the natural saponin QS-21, with immunoadjuvant activity. When co-administered with vaccine antigens, immunoadjuvant QS-DG may increase total antitumoral vaccine-specific antibody responses and cytotoxic T-lymphocyte (CTL) responses. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:QS-DG



Previous:imidazole mustard, imipenem, imiquimod, ImmTher, Immucell WGP
Next:immunotherapy regimen MKC-1106-MT, Immunox, Imodium A-D, IMP321, Imprime PGG

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov